title: Separate dosing of clopidogrel and omeprazole may improve platelet inhibition on dual antiplatelet therapy.
authors.forename: Bernadetta
authors.initials: B
authors.lastname: Chyrchel
authors.forename: Andrzej
authors.initials: A
authors.lastname: Surdacki
authors.forename: Michał
authors.initials: M
authors.lastname: Chyrchel
authors.forename: Dariusz
authors.initials: D
authors.lastname: Dudek
authors.forename: Jacek S
authors.initials: JS
authors.lastname: Dubiel
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D000077144:Clopidogrel; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000008:administration & dosage*; D010865:Pilot Projects; D015539:Platelet Activation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D004791:Enzyme Inhibitors; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D009853:Omeprazole; D013988:Ticlopidine